1.877.CLEVEMED (1.877.253.8363)

CleveMed News Releases

For More Information Contact:

Amy Rickard
Cleveland Medical Devices Inc.
Phone: 216.791.6720
arickard@clevemed.com
www.CleveMed.com


FOR IMMEDIATE RELEASE


CLEVELAND MEDICAL DEVICES INC. OBTAINS $615,000 IN NIH FUNDING FOR NEONATAL ICU TELEMETRY SYSTEM


CLEVELAND, OHIO, October 11, 2005 - Cleveland Medical Devices Inc. (CleveMed) announced that it has been awarded $615,000 in National Institutes of Health SBIR Phase II Continuation funding. The proceeds from the grant will fund the continuation and expansion of CleveMed's Neonatal ICU Telemetry System.

Currently, physiological and behavioral monitoring in the inpatient setting utilizes a large, cumbersome cart-mounted system that is tethered to the patient. This system is particularly troublesome in the neonatal intensive care unit (NICU). The goal of CleveMed's NICU Telemetry System is to provide a novel, practical, and inexpensive means of monitoring the physiological and behavioral state of neonates in the ICU, with potential applications for neonate and adult inpatient sleep disorders diagnosis. Unlike current cardio-respiratory systems on the market, the CleveMed version will provide video recordings while increasing the number of physiological parameters being collected; but at the same time, it will be significantly smaller and less expensive. As such, the CleveMed Neonatal ICU Telemetry System will not only provide the same information as the cardio-respiratory systems, but also all the power of cart-mounted EEG and polysomnography systems, all in a package that can be held in a laptop computer bag.

"I am enthusiastic about the efficacy of this device in our NICU," said Dr. Mark Scher, Director of Pediatric Sleep/Epilepsy and Fetal/Neonatal Neurology Programs at Rainbow Babies and Children's Hospital in Cleveland, Ohio. "From a patient monitoring standpoint, the NICU is an extremely challenging environment. The patients are small, medically fragile, and surrounded by bulky equipment. Continuous physiological monitoring can provide critical data that can guide diagnosis and treatment." Dr. Scher added, "Miniaturized wireless neurophysiologic monitoring at bedside would more efficiently monitor environmental consequences, which may lessen the stress to the high risk neonate."

According to the Principal Investigator, Joseph Giuffrida, Ph.D., "In developing this technology, we are excited to be utilizing our extensive experience in biomedical signal processing and instrumentation, while expanding our product offerings within our Brain Monitoring and Sleep Disorders Divisions."

About CleveMed

CleveMed was founded with the goal of developing innovative telemetry devices for a variety of medical applications. Today, CleveMed is developing and pioneering the use of novel wireless monitoring systems for high growth neurology and rehabilitation applications, including movement disorders, sleep disorders and brain monitoring. Through these innovations, CleveMed has developed a growing range of products that address the needs of the medical, research and academic communities. For more information, please visit www.CleveMed.com
Bookmark and Share

Request More Information

 
 
©1998-2012 Cleveland Medical Devices Inc.
4415 Euclid Ave (4th Floor), Cleveland OH 44103
Toll-free: 877.CleveMed | 877.253.8363
Phone: 216.791.6720 | Fax: 216.791.6739
24/7 Technical Support (Option 3)